TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
2.850
+0.050 (1.79%)
Dec 20, 2024, 4:00 PM EST - Market closed
TELA Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Revenue | 68.65 | 58.45 | 41.42 | 29.46 | 18.21 | 15.45 | Upgrade
|
| Revenue Growth (YoY) | 29.34% | 41.13% | 40.58% | 61.77% | 17.91% | 86.68% | Upgrade
|
| Cost of Revenue | 21.38 | 17.96 | 13.57 | 10.35 | 6.68 | 5.87 | Upgrade
|
| Gross Profit | 47.27 | 40.49 | 27.85 | 19.12 | 11.54 | 9.58 | Upgrade
|
| Selling, General & Admin | 83.04 | 74.57 | 57.11 | 41.52 | 32.25 | 24.28 | Upgrade
|
| Research & Development | 9.47 | 9.62 | 8.94 | 6.74 | 4.26 | 4.15 | Upgrade
|
| Operating Expenses | 92.89 | 84.57 | 66.86 | 48.57 | 36.81 | 28.74 | Upgrade
|
| Operating Income | -45.62 | -44.08 | -39.01 | -29.45 | -25.28 | -19.16 | Upgrade
|
| Interest Expense | -5.35 | -5.22 | -4.05 | -3.6 | -3.56 | -3.61 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.87 | 2.63 | -0.01 | -0.23 | 0.05 | 0.35 | Upgrade
|
| EBT Excluding Unusual Items | -49.1 | -46.66 | -43.07 | -33.28 | -28.79 | -22.43 | Upgrade
|
| Other Unusual Items | - | - | -1.23 | - | - | - | Upgrade
|
| Pretax Income | -41.52 | -46.66 | -44.3 | -33.28 | -28.79 | -22.43 | Upgrade
|
| Net Income | -41.52 | -46.66 | -44.3 | -33.28 | -28.79 | -22.43 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 7.78 | Upgrade
|
| Net Income to Common | -41.52 | -46.66 | -44.3 | -33.28 | -28.79 | -30.21 | Upgrade
|
| Shares Outstanding (Basic) | 25 | 23 | 16 | 14 | 13 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 25 | 23 | 16 | 14 | 13 | 2 | Upgrade
|
| Shares Change (YoY) | 14.27% | 40.58% | 12.40% | 11.90% | 632.24% | 498.81% | Upgrade
|
| EPS (Basic) | -1.69 | -2.04 | -2.72 | -2.30 | -2.23 | -17.10 | Upgrade
|
| EPS (Diluted) | -1.69 | -2.04 | -2.72 | -2.30 | -2.23 | -17.10 | Upgrade
|
| Free Cash Flow | -46.05 | -41.47 | -41.62 | -31.06 | -24.62 | -25.72 | Upgrade
|
| Free Cash Flow Per Share | -1.87 | -1.81 | -2.56 | -2.15 | -1.90 | -14.56 | Upgrade
|
| Gross Margin | 68.86% | 69.27% | 67.24% | 64.88% | 63.35% | 62.00% | Upgrade
|
| Operating Margin | -66.45% | -75.40% | -94.18% | -99.96% | -138.77% | -124.06% | Upgrade
|
| Profit Margin | -60.49% | -79.83% | -106.95% | -112.94% | -158.10% | -195.57% | Upgrade
|
| Free Cash Flow Margin | -67.07% | -70.94% | -100.49% | -105.42% | -135.19% | -166.52% | Upgrade
|
| EBITDA | -44.71 | -43.27 | -37.82 | -28.92 | -24.75 | -18.58 | Upgrade
|
| EBITDA Margin | -65.13% | -74.02% | -91.31% | -98.14% | -135.89% | -120.29% | Upgrade
|
| D&A For EBITDA | 0.91 | 0.81 | 1.19 | 0.54 | 0.53 | 0.58 | Upgrade
|
| EBIT | -45.62 | -44.08 | -39.01 | -29.45 | -25.28 | -19.16 | Upgrade
|
| EBIT Margin | -66.45% | -75.40% | -94.18% | -99.96% | -138.77% | -124.06% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.